The standing of Ameren among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ...

Microsoft Corp. shares have fallen recently along with other once-hot technology stocks in an unraveling of the artificial-intelligence trade — but Evercore ISI analysts aren’t sure that ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap company, ...

CenterPoint Energy (NYSE:CNP) +0.6% to multi-year highs in Tuesday's trading as Evercore ISI upgrades shares to ... Evercore's Durgesh Chopra writes, expecting shares to gain momentum throughout ...

CenterPoint upgraded at Evercore ISI, seeing the stock returning to its pre-2024 10%-plus premium vs. 5% currently with ...

Goldman Sachs analyst David Roman upgraded the rating for GE HealthCare Technologies Inc. GEHC from Neutral to Buy and boosted the price target from $85 to $100. GE HealthCare shares closed at $85.36 ...

Evercore ISI analyst Durgesh Chopra maintained a Buy rating on Essential Utilities (WTRG – Research Report) yesterday and set a price target of $46.00. The company’s shares closed yesterday at ...

On Tuesday, Evercore ISI analyst Durgesh Chopra maintained an In Line rating and a $12.00 price target for Hawaiian Electric... ByInvesting.com• 05 Mar 2025 BNP Paribas Exane cuts Target stock price ...

Evercore ISI analyst Durgesh Chopra maintained a Buy rating on Archrock (AROC – Research Report) yesterday and set a price target of $32.00. The company’s shares closed yesterday at $26.03.

Despite these investments, the market reacted negatively to the lower-than-expected earnings and guidance. Evercore ISI analyst Durgesh Chopra commented on the implications for Sempra’s stock, stating ...